Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines
SFDA hosts their 1st meeting of Arab Authorities Controlling Medicines, promoting Arab integration in the field of medicines control and legislation. Topics discussed included registration procedures, monitoring safety and quality, and the role of medicines control labs. Coordination and alignment with legal and regulatory requirements for medicines are key to facilitating availability and lowering costs for patients.
Recent Posts
TAVI Reimbursement Expansion for Low- and Intermediate-Risk Patients: A New Era in Cardiovascular...
The TAVI reimbursement expansion announced by Zorginstituut Nederland on March 10, 2026, includes transcatheter aortic valve implantation (TAVI) in...
Bridging Analyses: The Role of Cost Per Event Avoided in Evaluating GLP-1 Agonists
This editorial by Petrou et al., published in the Journal of Medical Economics, critiques escalating pharmaceutical expenditures amid new therapies like glucagon-like peptide-1 (GLP-1) receptor agonists for ty...
EU Medicines Regulation Achievements: EMA’s 2025 Highlights and Future Directions
The European Medicines Agency (EMA) Management Board highlights at its March 2026 meeting a robust year, with the adoption of the 2025 annual report detailing 104 positive recommendations for new hu...